CGIX insider transactions
Cancer Genetics, Inc. (CGIX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
CGIX insiders
Everyone who has filed a Form 3, 4, 5 or 144 at Cancer Genetics, Inc., latest first. Follow anyone to get their next filing.
- R John FletcherDirector, since March 2021
- Marcus BoehmDirector, since March 2021
- Joanna HorobinDirector, since March 2021
- Howard McLeodDirector
- Yung-Ping YehOfficer, Director
- Paul R. HansenDirector, since March 2021
- Geoffrey E. HarrisDirector
- Ralf BrandtOfficer
- Andrew D.C. LaFrenceOfficer, since March 2021
- John A RobertsOfficer
Recent Form 3, 4, and 5 filings for CGIX
- SEC Form 4: John R Fletcher was granted 8,676 units of Common Stock4 - Vyant Bio, Inc. (0001349929) (Issuer)
- SEC Form 4 filed by Marcus Boehm4 - Vyant Bio, Inc. (0001349929) (Issuer)
- SEC Form 4 filed by Joanna Horobin4 - Vyant Bio, Inc. (0001349929) (Issuer)
- SEC Form 4 filed by Howard Mcleod4 - Vyant Bio, Inc. (0001349929) (Issuer)
- SEC Form 4 filed by Yung-Ping Yeh4 - Vyant Bio, Inc. (0001349929) (Issuer)
- SEC Form 4 filed by R. Paul Hansen4 - Vyant Bio, Inc. (0001349929) (Issuer)
- SEC Form 4 filed by E. Geoffrey Harris4 - Vyant Bio, Inc. (0001349929) (Issuer)
- SEC Form 4 filed by Ralf Brandt4 - Vyant Bio, Inc. (0001349929) (Issuer)
- SEC Form 4 filed by D.C. Andrew Lafrence4 - Vyant Bio, Inc. (0001349929) (Issuer)
- SEC Form 4 filed by A John Roberts4 - Vyant Bio, Inc. (0001349929) (Issuer)
- SEC Form 3 filed by Marcus Boehm3 - Vyant Bio, Inc. (0001349929) (Issuer)
- SEC Form 3 filed by John R Fletcher3 - Vyant Bio, Inc. (0001349929) (Issuer)
- SEC Form 3 filed by Joanna Horobin3 - Vyant Bio, Inc. (0001349929) (Issuer)
- SEC Form 3 filed by D.C. Andrew Lafrence3 - Vyant Bio, Inc. (0001349929) (Issuer)
- SEC Form 3 filed by R. Paul Hansen3 - Vyant Bio, Inc. (0001349929) (Issuer)